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Abstract
Introduction: Here we present the case of a 56-year-old human immunodeficiency virus (HIV)-infected man with multiple anal
condylomas and positivity for human papilloma virus (HPV) 18 on anal brushing. Biopsies of the anal mucosa led to the diagnosis of
Bowen’s disease and a subsequent pelvic magnetic resonance imaging (MRI) scan evidencedmultiple reactive lymphoadenopathies
and large intra-anal condylomas. The patient was treated with a complete excision of Bowen’s lesion and with a 4 months course of
supplementation with a high concentration multistrain probiotic formulation administered orally and by rectal instillation with the
purpose to reduce local inflammation and to enhance local mucosal immunity.
Conclusion: An MRI performed at the end of the supplementation period evidenced the clearance of the anal condylomas
previously described and no evidence of residual lymphadenopathies. Trials are therefore required to confirm this therapeutic
possibility and for a better understanding of the mechanisms by which this specific probiotic formulation interacts with local
epithelium when administered by the anal route.
Abbreviations: AIN = anal intraepithelial neoplasia, HIV = human immunodeficiency virus, HPV = human papilloma virus, HSV =
herpes simplex virus, MR = magnetic resonance, MSM = man who have sex with men.
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The human immunodeficiency virus (HIV)-infected population
shows a higher prevalence of human papilloma virus (HPV)
infection and higher rates of HPV related dysplastic lesions in
comparison to the general population. Recent studies suggest that
the HIV related immune suppression and the interaction between
HIV and HPV themselves could be responsible for the increased
risk of HPV related malignancies in this population.[1–4]Editor: Akhilanand Chaurasia.
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1Moreover, while HIV-infected individuals almost invariably
show alterations of the normal composition of the gut microbial
flora,[5] evidences from literature highlight that a balanced
microbiota could exert a role in the clearance of HPV infection
thus preventing the risk of HPV related carcinogenesis.[6] In HIV
positive patients, gut dysbiosis is associated with impairment of
local immune system [7–9] and in this scenario any corrective
action may contribute to reduce the persistence of HPV infection
and subsequently to the onset of epithelial dysplasia.
The use of high doses of oral multistrain probiotics has been
investigated as a promising tool for the treatment of gut dysbiosis and
the restoration of gut mucosal immunity in HIV-infected people.[10]
Data about the effects of local rectal enema with probiotics on anal
HPV disease in HIV-infected individuals are unavailable.2. Case presentation
We present the case of a 56-year-old homosexual man who was
diagnosed with HIV infection in 1998 and which progressed to
AIDS in the same year (CD4 nadir 6cell/mL associated to
pneumonia due to Pneumocystis jirovecii, cervical Herpes Zoster,
and disseminated nontuberculous mycobacterial infection).
During the follow-up, the patient continuously showed poor
adherence to antiretrovirals and required numerous therapy
switch due to virological failure. His medical records showed
other pathologic conditions such as thyroid nodular disease,
arterial hypertension, syphilis, recurrent anal warts repeatedly
treated with diathermocoagulation and persistent positivity of
HPV 18 in anal brushing.
Figure 1. Histology section of Bowen’s disease lesion.
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resolution anoscopy (HRA), it was highlighted the presence of
multiple intra anal condylomas. Bioptic samples of the anal
mucosa led to the diagnosis of squamocellular intraepithelial
carcinoma (Bowen’s disease, anal intraepithelial neoplasia AIN3)
(Fig. 1), with an incomplete excision of the lesion. A pelvic MRI
scan evidenced granulation tissue in the location of the recent
biopsy, without radiological evidence of residual pathological
tissue. The MRI also evidenced multiple condylomas of the anal
canal, reactive mesorectal and pelvic lymphadenopathies,
reactive lymphnodes along the sigmoidal vessels, and thickening
of the mesorectum (Fig. 2A). At the time of anal Bowen’s disease
diagnosis, the patient was clinically asymptomatic and showed a
good immune-virological status with a CD4 count of 818cells/mL
(28.27%) and HIV-RNA persistently undetectable since 2014.
Given the fact that Bowen’s disease is considered a high grade
dysplasia (AIN3) with a low risk of invasion (around 5%), we
adopted a conservative approach undergoing a complete excision
of the lesion and, once achieved, proposing to the patient a courseFigure 2. Pelvic MRI scan performed before (A) and after (B) supplementa
2of supplementation with a multistrain probiotic with daily
endorectal instillation of 900 billion live bacteria and daily oral
administration of 3 sachets, each containing 450 billion live
bacteria (probiotic composition: Lactobacillus plantarum DSM
24730, Streptococcus thermophilus DSM 24731, Bifidobacte-
rium breve DSM 24732, Lactobacillus paracasei DSM 24733,
Lactobacillus delbrueckii subsp, bulgaricus DSM 24734,
Lactobacillus acidophilus DSM 24735, Bifidobacterium longum
DSM 24736, and Bifidobacterium infantis DSM 24737;
commercially available as Vivomixx in Europe, Visbiome in
USA and DeSimone Formulation in Korea), with the aim to
reduce local inflammation and to rebalance local microbiota,
thus possibly restoring in site mucosal immunity.
After 4 months of supplementation, a new pelvic MRI scan
evidenced the spot of the previous biopsy but no evidence of
mesorectal, iliac, and pelvic lymphadenopathies. Moreover,
clearance of the anal condylomas previously described was noted
(Fig. 2B) despite HPV18 DNA was still detectable.
Six months later, the patient underwent a new HRA that
showed no evidence of condyloma.3. Discussion
This case report suggests a potential role for this specific probiotic
formulation in promoting the regression of anal HPV related
lesions in HIV-infected individuals. The effects of a number of
oral probiotic formulation on HPV associated alterations have
been mainly studied in the female genital tract; in a prospective
controlled pilot study, women with HPV associated low-grade
squamous intraepithelial lesions were randomized for probiotic
supplementation: the treated group showed a higher chance of
clearing HPV infection (29% vs 19%, P= .41) and higher rates of
clearance of HPV associated cytological abnormalities (60% vs
31%; P= .05) in comparison to the control group.[11] Other
evidences show that a reduced amount of Lactobacillus spp.
combined with an increased diversity of the vaginal microbiota
could be involved in HPV acquisition and persistence and in the
development of dysplastic cervical lesions[12,13]; moreover, in
vitro studies demonstrated a direct cytotoxic effect of certaintion with rectal and oral probiotics. MRI=magnetic resonance imaging.
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of the expression of HPV E6 and E7 oncogenes, which may
prevent malignant transformation in individuals harboring high-
risk HPV genotypes.[14–16]
Based on the findings of the mentioned gynecological studies,
in which the prescription of probiotic supplementation seems
related with the regression of HPV related female genital tract
lesions, its our opinion that probiotics could also exerted a
therapeutic role in our patient. In fact, despite at the moment
there are no similar direct evidences for anal condylomatosis, we
believe that the effects of probiotic strains (described for female
genital tract) are also possible in the anal district, as observed in
this case.
Moreover in HIV positive patients, dysbiosis of the gut
microbiota largely contributes to the impairment of mucosal
immunity and could facilitate HPV persistence and the subse-
quent epithelial transformation. Given that spontaneous regres-
sion of multiple large condylomas, such as those observed in our
patient, is not frequently seen among HIV-infected patients, we
hypothesize a beneficial role exerted by this specific probiotic
formulation in the clearance of HPV related lesions.
Finally, data on the effects of probiotic rectal enema on anal
HPV infection in HIV positive males are lacking. Given the
extremely distal localization of the HPV related lesions of our
patient, we decided to use, together with oral administration,
rectal enemas of probiotics to maximize the amount of bacterial
cells that would reach the anal canal to effectively interact with
the local epithelium.4. Conclusions
Growing evidences show the potential beneficial effect of
probiotics on HPV related disease, also in anal district. In
particular, in HIV-infected individuals, due to the impairment of
the immune response and the loss of gut intraepithelial
lymphocytes, lower rates of HPV clearance are observed and
consequently spontaneous resolution of multiple large anal
condylomas is rare among this population. For this reason, the
positive results of our preliminary experience support the
hypothesis of a direct efficacy of oral and rectal multistrain
probiotic administration in the treatment of anal condylomatosis
in HIV-infected patients.Author contributions
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